In search of definitions: Cancer‐associated fibroblasts and their markers

The tumor microenvironment has been identified as one of the driving factors of tumor progression and invasion. Inside this microenvironment, cancer‐associated fibroblasts (CAFs), a type of perpetually activated fibroblasts, have been implicated to have a strong tumor‐modulating effect and play a key role in areas such as drug resistance. Identification of CAFs has typically been carried based on the expression of various “CAF markers”, such as fibroblast activation protein alpha (FAP) and alpha smooth muscle actin (αSMA), which separates them from the larger pool of fibroblasts present in the body. However, as outlined in this Review, the expression of various commonly used fibroblast markers is extremely heterogeneous and varies strongly between different CAF subpopulations. As such, novel selection methods based on cellular function, as well as further characterizing research, are vital for the standardization of CAF identification in order to improve the cross‐applicability of different research studies in the field. The aim of this review is to give a thorough overview of the commonly used fibroblast markers in the field and their various strengths and, more importantly, their weaknesses, as well as to highlight potential future avenues for CAF identification and targeting.

[1]  The Roles of PDGF in Development and During Neurogenesis in the Normal and Diseased Nervous System , 2013, Journal of Neuroimmune Pharmacology.

[2]  C. Sautès-Fridman,et al.  The immune contexture of primary and metastatic human tumours. , 2014, Current opinion in immunology.

[3]  Camille Stephan-Otto Attolini,et al.  Stromal gene expression defines poor-prognosis subtypes in colorectal cancer , 2015, Nature Genetics.

[4]  Kevin W Eliceiri,et al.  A subset of myofibroblastic cancer-associated fibroblasts regulate collagen fiber elongation, which is prognostic in multiple cancers , 2015, Oncotarget.

[5]  L. J. K. Wee,et al.  Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors , 2017, Nature Genetics.

[6]  J. Isaacs,et al.  Rationale Behind Targeting Fibroblast Activation Protein–Expressing Carcinoma-Associated Fibroblasts as a Novel Chemotherapeutic Strategy , 2012, Molecular Cancer Therapeutics.

[7]  T. Dominko,et al.  FGF2 Overrides TGFβ1‐Driven Integrin ITGA11 Expression in Human Dermal Fibroblasts , 2016, Journal of cellular biochemistry.

[8]  James O. Jones,et al.  Suppression of Antitumor Immunity by Stromal Cells Expressing , 2022 .

[9]  Daniel Öhlund,et al.  Fibroblast heterogeneity in the cancer wound , 2014, The Journal of experimental medicine.

[10]  C. Datz,et al.  Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver , 2010, Proceedings of the National Academy of Sciences.

[11]  E. Bruyneel,et al.  Tenascin‐C and SF/HGF produced by myofibroblasts in vitro provide convergent proinvasive signals to human colon cancer cells through RhoA and Rac , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  S. Watson,et al.  Podoplanin-expressing inflammatory macrophages activate murine platelets via CLEC-2 , 2012, Journal of thrombosis and haemostasis : JTH.

[13]  E. Schuuring,et al.  Tyrosine kinase inhibitor sensitive PDGFRΑ mutations in GIST: Two cases and review of the literature , 2017, Oncotarget.

[14]  Min Shi,et al.  Expression of fibroblast activation protein in human pancreatic adenocarcinoma and its clinicopathological significance. , 2012, World journal of gastroenterology.

[15]  I. Stamenkovic Matrix metalloproteinases in tumor invasion and metastasis. , 2000, Seminars in cancer biology.

[16]  K. Okada,et al.  Increased expression of seprase, a membrane-type serine protease, is associated with lymph node metastasis in human colorectal cancer. , 2003, Cancer letters.

[17]  F. Peale,et al.  Tumor-Driven Paracrine Platelet-Derived Growth Factor Receptor α Signaling Is a Key Determinant of Stromal Cell Recruitment in a Model of Human Lung Carcinoma , 2006, Clinical Cancer Research.

[18]  H. Yao,et al.  CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness , 2018, Cell.

[19]  D. Tuveson,et al.  IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma. , 2018, Cancer discovery.

[20]  Steven Song,et al.  The role of pericytes in blood-vessel formation and maintenance. , 2005, Neuro-oncology.

[21]  B. Coulomb,et al.  The myofibroblast, multiple origins for major roles in normal and pathological tissue repair , 2012, Fibrogenesis & tissue repair.

[22]  I. Kovalszky,et al.  Tumor-produced, active Interleukin-1 β regulates gene expression in carcinoma-associated fibroblasts , 2011, Experimental cell research.

[23]  R. Kalluri The biology and function of fibroblasts in cancer , 2016, Nature Reviews Cancer.

[24]  C. Robert,et al.  Melanoma-associated fibroblasts decrease tumor cell susceptibility to NK cell-mediated killing through matrix-metalloproteinases secretion , 2017, Oncotarget.

[25]  B. Hennessy,et al.  Adipose tissue derived stem cells differentiate into carcinoma-associated fibroblast-like cells under the influence of tumor derived factors , 2011, Cellular Oncology.

[26]  N. Davidson,et al.  Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M. Delorenzi,et al.  Identification of Prognostic Molecular Features in the Reactive Stroma of Human Breast and Prostate Cancer , 2011, PloS one.

[28]  A. Turtoi,et al.  Paracrine interactions of cancer-associated fibroblasts, macrophages and endothelial cells: tumor allies and foes , 2018, Current opinion in oncology.

[29]  S. Ha,et al.  The Prognostic Significance of Cancer-Associated Fibroblasts in Esophageal Squamous Cell Carcinoma , 2014, PloS one.

[30]  T. Oskarsson,et al.  Tenascin C in metastasis: A view from the invasive front , 2015, Cell adhesion & migration.

[31]  Inna Kuperstein,et al.  Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer. , 2018, Cancer cell.

[32]  W. Birchmeier,et al.  Cancer Stem Cells Regulate Cancer-Associated Fibroblasts via Activation of Hedgehog Signaling in Mammary Gland Tumors. , 2017, Cancer research.

[33]  A. Vincent-Salomon,et al.  miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers , 2018, Nature Communications.

[34]  Mark W. Kieran,et al.  Identification of fibroblast heterogeneity in the tumor microenvironment , 2006, Cancer biology & therapy.

[35]  I. Amelio,et al.  The hypoxic tumour microenvironment , 2018, Oncogenesis.

[36]  A Riedl,et al.  Stromal-derived IGF2 promotes colon cancer progression via paracrine and autocrine mechanisms , 2017, Oncogene.

[37]  Hans Clevers,et al.  Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer , 2017, The Journal of experimental medicine.

[38]  N. Erez,et al.  From sentinel cells to inflammatory culprits: cancer‐associated fibroblasts in tumour‐related inflammation , 2013, The Journal of pathology.

[39]  D. Gullberg,et al.  Integrin α11β1: a major collagen receptor on fibroblastic cells. , 2014, Advances in experimental medicine and biology.

[40]  Xiao-En Xu,et al.  Identification of colonic fibroblast secretomes reveals secretory factors regulating colon cancer cell proliferation. , 2014, Journal of proteomics.

[41]  C. Heldin,et al.  Targeting the PDGF signaling pathway in tumor treatment , 2013, Cell Communication and Signaling.

[42]  G. Kollias,et al.  IKKβ in intestinal mesenchymal cells promotes initiation of colitis-associated cancer , 2015, The Journal of experimental medicine.

[43]  N. Ashley,et al.  Myofibroblasts are distinguished from activated skin fibroblasts by the expression of AOC3 and other associated markers , 2016, Proceedings of the National Academy of Sciences.

[44]  M. Taketo,et al.  Stromal Fibroblasts Activated by Tumor Cells Promote Angiogenesis in Mouse Gastric Cancer* , 2008, Journal of Biological Chemistry.

[45]  S. Mok,et al.  CAF reprogramming inhibits ovarian cancer progression , 2014, Cell cycle.

[46]  I. Ng,et al.  Cancer-Associated Fibroblasts Regulate Tumor-Initiating Cell Plasticity in Hepatocellular Carcinoma through c-Met/FRA1/HEY1 Signaling. , 2016, Cell reports.

[47]  Tuan Zea Tan,et al.  A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets. , 2016, Cancer letters.

[48]  Robert A. Weinberg,et al.  Autocrine TGF-β and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts , 2010, Proceedings of the National Academy of Sciences.

[49]  W. Aulitzky,et al.  Dasatinib reverses Cancer-associated Fibroblasts (CAFs) from primary Lung Carcinomas to a Phenotype comparable to that of normal Fibroblasts , 2010, Molecular Cancer.

[50]  J. Bergh,et al.  High expression of stromal PDGFRβ is associated with reduced benefit of tamoxifen in breast cancer , 2016, The journal of pathology. Clinical research.

[51]  Nikolina Radulovich,et al.  Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer , 2011, Proceedings of the National Academy of Sciences.

[52]  G. Charras,et al.  Hypoxia and loss of PHD2 inactivate stromal fibroblasts to decrease tumour stiffness and metastasis , 2015, EMBO reports.

[53]  E. Martin,et al.  Concise Medical Dictionary , 2010 .

[54]  M. A. Huber,et al.  Fibroblast activation protein: differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors. , 2003, The Journal of investigative dermatology.

[55]  A. Kozubík,et al.  The fibroblast surface markers FAP, anti‐fibroblast, and FSP are expressed by cells of epithelial origin and may be altered during epithelial‐to‐mesenchymal transition , 2018, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[56]  F. Cañada,et al.  Vimentin filament organization and stress sensing depend on its single cysteine residue and zinc binding , 2015, Nature Communications.

[57]  Liming Huang,et al.  Tumor-Infiltrating Podoplanin+ Fibroblasts Predict Worse Outcome in Solid Tumors , 2018, Cellular Physiology and Biochemistry.

[58]  H. Kijima,et al.  Expression of cancer-associated fibroblast markers in advanced colorectal cancer , 2018, Oncology letters.

[59]  Erwin F. Wagner,et al.  Cancer: Fibroblasts for all seasons , 2016, Nature.

[60]  P. McKee,et al.  Phase II trial of single agent Val-boroPro (talabostat) inhibiting fibroblast activation protein in patients with metastatic colorectal cancer , 2007, Cancer biology & therapy.

[61]  A. G. de Herreros,et al.  Functional Heterogeneity of Cancer-Associated Fibroblasts from Human Colon Tumors Shows Specific Prognostic Gene Expression Signature , 2013, Clinical Cancer Research.

[62]  David J. Beebe,et al.  Understanding the Impact of 2D and 3D Fibroblast Cultures on In Vitro Breast Cancer Models , 2013, PloS one.

[63]  V. Calvo,et al.  Cancer‐associated fibroblasts modify lung cancer metabolism involving ROS and TGF‐&bgr; signaling , 2019, Free radical biology & medicine.

[64]  A. Ignatchenko,et al.  Proteomic Analysis of Cancer-Associated Fibroblasts Reveals a Paracrine Role for MFAP5 in Human Oral Tongue Squamous Cell Carcinoma. , 2018, Journal of proteome research.

[65]  Kristian Pietras,et al.  High interstitial fluid pressure — an obstacle in cancer therapy , 2004, Nature Reviews Cancer.

[66]  D. Murawa,et al.  Occurence of stromal myofibroblasts in the invasive ductal breast cancer tissue is an unfavourable prognostic factor. , 2007, Anticancer research.

[67]  R. Sanz-Pamplona,et al.  Differences between CAFs and their paired NCF from adjacent colonic mucosa reveal functional heterogeneity of CAFs, providing prognostic information , 2014, Molecular oncology.

[68]  P. Gascard,et al.  Carcinoma-associated fibroblasts: orchestrating the composition of malignancy , 2016, Genes & development.

[69]  Dennis C. Sgroi,et al.  Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion , 2005, Cell.

[70]  C. Isacke,et al.  Tumour cell-derived Wnt7a recruits and activates fibroblasts to promote tumour aggressiveness , 2016, Nature Communications.

[71]  E. Lengyel,et al.  MicroRNAs reprogram normal fibroblasts into cancer-associated fibroblasts in ovarian cancer. , 2012, Cancer discovery.

[72]  Magdi H Yacoub,et al.  Expression of smooth muscle cell markers and co-activators in calcified aortic valves. , 2015, European heart journal.

[73]  M. Provencio,et al.  Cancer‐associated fibroblast and M2 macrophage markers together predict outcome in colorectal cancer patients , 2013, Cancer science.

[74]  Olivier De Wever,et al.  Cancer-Associated Fibroblasts Connect Metastasis-Promoting Communication in Colorectal Cancer , 2015, Front. Oncol..

[75]  I Jurisica,et al.  Integrin α11β1 regulates cancer stromal stiffness and promotes tumorigenicity and metastasis in non-small cell lung cancer , 2015, Oncogene.

[76]  M. Monden,et al.  Stromal Myofibroblasts Predict Disease Recurrence for Colorectal Cancer , 2007, Clinical Cancer Research.

[77]  A. Bossie,et al.  CD90 Expression on human primary cells and elimination of contaminating fibroblasts from cell cultures , 2009, Cytotechnology.

[78]  F. Greten,et al.  IKKβ acts as a tumor suppressor in cancer-associated fibroblasts during intestinal tumorigenesis , 2015, The Journal of experimental medicine.

[79]  Triantafyllos Stylianopoulos,et al.  Defining the Role of Solid Stress and Matrix Stiffness in Cancer Cell Proliferation and Metastasis , 2018, Front. Oncol..

[80]  G. Mazzoccoli,et al.  Friend or foe? The tumour microenvironment dilemma in colorectal cancer. , 2017, Biochimica et biophysica acta. Reviews on cancer.

[81]  Y. Xuan,et al.  Twist1 is highly expressed in cancer-associated fibroblasts of esophageal squamous cell carcinoma with a prognostic significance , 2017, Oncotarget.

[82]  U. Müller-Ladner,et al.  Cell culture and passaging alters gene expression pattern and proliferation rate in rheumatoid arthritis synovial fibroblasts , 2010, Arthritis research & therapy.

[83]  A. Orimo,et al.  The roles of tumor- and metastasis-promoting carcinoma-associated fibroblasts in human carcinomas , 2016, Cell and Tissue Research.

[84]  S. Ponnazhagan,et al.  Silencing of TGF-β1 in tumor cells impacts MMP-9 in tumor microenvironment , 2017, Scientific Reports.

[85]  P. Jung,et al.  Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation. , 2012, Cancer cell.

[86]  K. Sukhdeo,et al.  Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A , 2013, The Journal of experimental medicine.

[87]  J. Galván,et al.  COL11A1/(pro)collagen 11A1 expression is a remarkable biomarker of human invasive carcinoma-associated stromal cells and carcinoma progression , 2015, Tumor Biology.

[88]  Janna Paulsson,et al.  Prognostic relevance of cancer-associated fibroblasts in human cancer. , 2014, Seminars in cancer biology.

[89]  R. Eferl,et al.  Autocrine WNT2 signaling in fibroblasts promotes colorectal cancer progression , 2017, Oncogene.

[90]  K. De Bosscher,et al.  Colon cancer-derived myofibroblasts increase endothelial cell migration by glucocorticoid-sensitive secretion of a pro-migratory factor , 2017, Vascular pharmacology.

[91]  S. Haan,et al.  Tumor-Initiating Cells: a criTICal review of isolation approaches and new challenges in targeting strategies , 2017, Molecular Cancer.

[92]  N. Erez,et al.  Isolation of normal and cancer-associated fibroblasts from fresh tissues by Fluorescence Activated Cell Sorting (FACS). , 2013, Journal of visualized experiments : JoVE.

[93]  J. Yokota,et al.  TSPAN12 is a critical factor for cancer–fibroblast cell contact-mediated cancer invasion , 2014, Proceedings of the National Academy of Sciences.

[94]  C. Heldin,et al.  Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[95]  M. Takeya,et al.  CAFs and TAMs: maestros of the tumour microenvironment , 2017, The Journal of pathology.

[96]  G. Semenza,et al.  Hypoxia Selectively Enhances Integrin α5β1 Receptor Expression in Breast Cancer to Promote Metastasis , 2017, Molecular Cancer Research.

[97]  T. Oyama,et al.  Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages , 2016, Oncotarget.

[98]  Helmut Friess,et al.  The activated stroma index is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[99]  Sami Blom,et al.  Capturing tumor complexity in vitro: Comparative analysis of 2D and 3D tumor models for drug discovery , 2016, Scientific Reports.

[100]  M. Kojima,et al.  Podoplanin, a novel marker of tumor-initiating cells in human squamous cell carcinoma A431. , 2008, Biochemical and biophysical research communications.

[101]  Liang Xie,et al.  Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. , 2007, Cancer research.

[102]  D. Jäger,et al.  Stromal Antigen Targeting by a Humanised Monoclonal Antibody: An Early Phase II Trial of Sibrotuzumab in Patients with Metastatic Colorectal Cancer , 2003, Oncology Research and Treatment.

[103]  P. De Marco,et al.  GPER signalling in both cancer-associated fibroblasts and breast cancer cells mediates a feedforward IL1β/IL1R1 response , 2016, Scientific Reports.

[104]  Peter Olson,et al.  Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner. , 2010, Cancer cell.

[105]  Robert A. Weinberg,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[106]  G. Inghirami,et al.  Stromal contribution to the colorectal cancer transcriptome , 2015, Nature Genetics.

[107]  Y. Nordby,et al.  High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence , 2017, Scientific Reports.